The male god of magic capital

Cheng Tian Holdings, Luo Cheng pulled his fingers, took a deep breath: "Finally, the position is completed."

This time, Pharmaron Chemicals, which has invested HK$10 billion in Hong Kong stocks, has an average price of opening positions at 50 yuan per share, holding 2000 million shares, and a temporary floating profit of HK$4000 million.

The A-share account also holds 2000 million shares of Pharmaron. Today, the A-share Pharmaron closed at 22 yuan per share, with a floating loss of 8 yuan per share, and a total floating loss of 1.6 million.

"Peng Shuxiang of Dashuai Assets is so firm in his belief that the stock price bubble in the CRO industry will burst, but this can only happen when the stock market has been going bearish. At present, A shares and Hong Kong stocks have only continued to fall and have not entered a bear market, so Once the stock market continues to go bullish, the stock price of Pharmaron can still take off again."

Luo Cheng knows that the stock price bubble in the CRO industry is very serious, Wu Tianhai knows it, Henry Cizek knows it, Peng Shuxiang of Dashuai Assets knows it, Dayan Capital, Suzaku Investment, and Danshuiquan Investment also know it.

But everyone’s choices are different. Peng Shuxiang of Dashuai Assets directly chose to leave early, while Luo Cheng and others chose to continue to push up the bubble. Now there is still a long way to go before the bubble bursts, far from this year.

This time, Luo Cheng intends to hold Kanglong Huacheng's stock for a long time, and it will not be a problem to double it several times. Of course, the premise is that the stock market will go bullish, which will drive the stock price of the CRO industry to rise.

Of course, if it can double in the short term, that would be very good, and Luo Cheng will also withdraw in a short time. After all, if the stock market is booming and skyrocketing, the share price of Pharmaron Chemicals can still take off in the short term.

Regardless, Dayan Capital, Suzaku Investment, and Danshuiquan Investment are three large private equity funds that are silent. Once the stock market is bullish and they increase their positions in Pharmaron, the stock price will also take off quickly.

At this time Jiang Manman came over.

"Boss, Lou Huaqiang, the founder of Pharmaron Chemicals, called. He wants to talk to you."

"Oh?" Luo Cheng was taken aback, Lou Huaqiang, the founder of Kanglong Huacheng?
The news said that Lou Huaqiang pledged his equity in the company, obtained a loan, and then invested in other industries, but lost money.

This time, Peng Shuxiang, who owns the assets of the Marshal, shorted Kang Longhuacheng, and it was like killing Lou Huaqiang to death!
Once the pledged equity is forcibly liquidated by the bank, then Lou Huaqiang will be finished.

"Let me talk to him!"

The call will be connected soon.

"Hello, Mr. Luo, I'm Lou Huaqiang, the founder of Pharmaron Chemicals." There was a burst of blunt words on the phone.

"Hello, Mr. Lou, I didn't expect you to call me suddenly. Haha, it's a pleasure to meet you. You are a leader in the CRO industry. Many people have mentioned you in front of me." Luo Cheng said.

"Hey, Mr. Luo, I'm just a lucky entrepreneur. The situation is very bad now. I pledged my equity to invest in other industries. If I didn't do well, the pledged equity was almost forcibly liquidated by the bank." Lou Huaqiang was grateful on the phone He said: "Mr. Luo, thank you Kang Longhua, who has boosted the Hong Kong stock market this time."

Luo Cheng smiled and said, "Actually, I am very optimistic about Kang Longhua's future prospects."

Lou Huaqiang smiled wryly: "The stock price bubble in the CRO industry is very serious. I am also very unlucky. The equity pledge line is very high. If the stock price continues to fall, the bank will ask me to protect the market. Fortunately, you have pulled the Hong Kong stock market, Pharmaron, into a stock price. Otherwise, I will have to raise funds to raise the stock price, and I don’t know if I can raise it, and now I have to watch its Hong Kong stock and A-share stock prices every day.”

Luo Cheng asked: "Mr. Lou, have you pledged the shares of Hong Kong shares and A shares?"

Lou Huaqiang: "Yes, I don't have so many Hong Kong dollars to protect the market in Hong Kong stocks, but for A shares, I can borrow some money to protect the market. It should be no problem."

Luo Cheng nodded: "Mr. Lou, what's the situation with your other industries?"

Lou Huaqiang began to talk to Luo Cheng about his other companies, because in Kanglong Chemical Company, he didn't have many things to do, and the company had entered a steady development mode, so it was good to leave it to his original team. In fact, from the moment Kanglong Chemical was listed, he no longer needed to worry about the company's affairs. Later, Tianhai Group, Jardine Group, and Nuoan Group joined in, which led to Kanglong Chemical's work with Shenzhou Baekje Company. The guy eroded Kang Long's power step by step and bought many people. He, the founder, was gradually seized power, and the marshal's assets sometimes stood by Wu Tianhai's side, which made him very passive.

Although the three parties check and balance each other in Kanglong Huacheng, Dashuai's assets have now retreated, and there are three large private equity funds, Dayan Capital, Suzaku Investment, and Danshuiquan Investment.

The founders of these three private equity funds have a good relationship with Tianhai Group, and they must support Wu Tianhai. In this case, Wu Tianhai’s votes will be as high as 27%. Basically, these guys can control Kanglong Huacheng up.

"Mr. Luo, it's not up to me to decide Kang Long's transformation now, it's up to Wu Tianhai and the others."

Luo Cheng said with a smile: "Mr. Lou, you have other industries, just lie down and take the money. Dayan Capital, Suzaku Investment, and Danshuiquan Investment are not necessarily the same as Wu Tianhai. They also want to see Kang Long when they come in. The stock price of Huacheng will rise to a high level in the future to cash out, as I said, I now hold 4000 million shares, plus my friend holds a lot of shares, everyone is united, Wu Tianhai can't do whatever he wants."

Lou Huaqiang said with a smile: "I hope so, I am now focusing on the other two companies."

"Now I still have two companies under my umbrella. One is listed and the other is not listed. I have invested a lot of money. It's hard to say."

"The development of the listed company called Anbiping Pharmaceuticals has been blocked, and it has grabbed a lot of orders. The market value has been shrinking, and the liquidity has become tighter. The Xiangjiang Consortium behind the Cangshan Group."

When Luo Cheng heard it, Cangshan Group and Anbiping Pharmaceutical Company are rivals?
And American Amgen?

The Xiangjiang Consortium behind Liu Cangshan?

Good guy.

Luo Cheng looked at the stock price chart of Anbiping Medicine, and found that its market value had shrunk from a peak of 55 billion to 18 billion, and the stock price had fallen so badly.

"Mr. Lou, how much money do you still need for Anbiping Medicine?"

Lou Huaqiang said: "5 million, I found a bank loan of 3 million, and I raised 2 million myself. This Liu Cangshan wants to acquire Anbiping Pharmaceutical Company, and I don't want him to acquire it."

Luo Cheng said, "I'll raise 2 million for you!"

Lou Huaqiang was immediately overjoyed. He knew that Luo Cheng and Liu Cangshan would have trouble with each other. The Cangshan Group had fought fiercely with the companies under Chengtian Holdings many times, making the subsidiaries of Chengtian Holdings quite embarrassing.

The relationship between Luo Cheng and Liu Cangshan is simply like fire and water.

He immediately agreed to let Luo Cheng raise money.

"Mr. Luo, happy cooperation!"

Luo Cheng: "Mr. Lou, I'll send someone over to sign an agreement with you right away!"

Previously, Chengtian public offering fund raised 100 billion yuan, collected 2.5 million yuan in management fees, and allocated 2 million yuan to the strategic investment department, leaving 5000 million yuan as daily operating funds.

Then the strategic investment department of Chengtian Holdings raised 2 million yuan for Lou Huaqiang's Anbiping Pharmaceutical, obtained 10% of the equity, and appointed a director.

Supporting Anbiping Pharmaceutical Company is another attack on the enemy Liu Cangshan, Luo Cheng is very happy.

Lou Huaqiang: "Mr. Luo, I will concentrate on developing Anbiping Medicine from now on. This Liu Cangshan will soon see how good I am!"

Luo Cheng said with a smile: "Haha, I believe in Mr. Lou, you have made the achievement of Kanglonghua, and I believe that you can also do Anbiping medicine."

Lou Huaqiang thought for a while and said, "Mr. Luo, I really want to hide it. I'm not very optimistic about the future prospects of Kanglong Chemical, because there is a huge industry bubble in it. I also plan to cash out and leave the market after the stock price rises in the future. , sell all stocks."

The prospect of Pharmaron is actually not very optimistic. There is a huge bubble in the industry. He plans to cash out and leave the market when the stock price rises in the future, and let Wu Tianhai and the others play by themselves.

Luo Cheng smiled and said, "Actually, we think the same thing!"

Lou Huaqiang: "I hope the A shares will rise sooner!"

Luo Cheng smiled and said: "Soon, this A-share market can no longer fall, and it will rise sharply soon!"

···
Time flies, Wednesday and Thursday passed quickly, A shares rose slightly, and Pharmaron's stock price has been oscillating.

On Friday, the A-share market began to soar!

The trading volume of all major sectors has soared!
The medical sector soared! !
The share price of Pharmaron has also been bought by a large number of funds.

For the A-shares, the share price of Pharmaron Chemicals rushed to 30 yuan a share, and the Luo Family Foundation's A-share account no longer lost money.

On the Hong Kong stock market, the share price of Pharmaron Chemicals soared to 55 yuan a share, and the Hong Kong stock account of the L Luo Family Foundation had a floating profit of 1 million Hong Kong dollars.

And today's medical sector has also risen a lot!
Jiu'an Medical Group, +12%
WuXi AppTec Group, +9.54%
Jianfan Bio, +9.12%
Opcon, +14.87%
Mindray Medical, +8.78%
Yuwell Medical, +10.12%
Lepu Medical, +11.12%
Fosun Pharma, +9.12%
Tongce Medical, +12.23%
Watson Bio, +14.87%
Hengrui Medicine, +9.78%
Aier Ophthalmology, +7.41%
Zhifei creatures, +10.25%
Huadong Medicine, +12.75%
Tigermed, +11.78%
Hengrui Medicine, +8.77%
Pien Tze Huang, +9.41%
Changyin High-tech, +11.11%
Asymchem, +10.78%
The scale of Chengtian Hybrid Pioneer has returned to 1100 billion again!
And Chengtian Private Equity Fund holds 1 million shares of Zhifei Biology, and the stock price has rushed to 130 yuan per share, worth 130 billion.

Holding Hengrui Medicine, 4 million shares, the stock price rushed to 35 yuan per share, worth 140 billion.

Holding WuXi AppTec, 2 million shares, the stock price rushed to 70 yuan per share, worth 150 billion.

150 billion, 8000 million shares of Mindray Medical, the stock price rushed to 200 yuan a share, worth 160 billion.

The total scale of Chengtian Private Equity Fund has reached 580 billion!
The stock price of Chengtian Holdings hit a new high again today. Because of the rise in A-shares, Chengtian Holdings had a big swing, from 3.7 yuan per share to 4 yuan per share, with a market value of as high as 400 billion!
The Roche Family Foundation holds 75% of the shares, worth 300 billion!